Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

165 recalls · Class III, newest first

Class III · Low risk

PreviDent 5000 ppm

Label Mix up; rear panel is incorrectly labeled with the PreviDent 5000 Enamel Protect rear panel.

Terminated Labeling / mix-up Colgate Palmolive Co NDC 0126-0016-61 D-0521-2017
Class III · Low risk

Salicylic Acid Cream

Failed Impurities/Degradation Specifications: The API for these products had an out of specification result for an organic impurity.

Terminated Impurity / degradation L. Perrigo Company NDC 45802-806-01 D-0504-2017
Class III · Low risk

Salicylic Acid Shampoo

Failed Impurities/Degradation Specifications: The API for these products had an out of specification result for an organic impurity.

Terminated Impurity / degradation L. Perrigo Company NDC 45802-237-01 D-0503-2017
Class III · Low risk

Levofloxacin Ophthalmic Solution

Failed Impurities/ Degradation Specifications: OOS for related compound (levofloxacin n-oxide) at the 18 month stability time point.

Terminated Impurity / degradation Actavis Inc NDC 50383-283-05 D-0514-2017
Class III · Low risk

Q Care Continue Care Kit for the non-ventilated patient

Labeling: Incorrect or Missing Lot and/or Exp Date: The expiration date of the Q Care Continue Care kit is printed with an expiration date of November 13, 2017; rather than the correct date of August 28, 2017 (date of expiration of the Corinz Antiseptic Cleansing & Moisturizing Oral Rinse). Note, the correct expiration date of August 28, 2017, is printed on the Corinz Oral Rinse package.

Terminated Labeling / mix-up Sage Products Inc D-0489-2017
Class III · Low risk

Norethindrone Acetate and Ethinyl Estradiol Tablets

Chemical Contamination: out of specification results for impurities were found to be the result of contamination of product from vapors associated with paint thinner used in repair of the manufacturing room.

Terminated Chemical / undeclared Mylan Pharmaceuticals Inc. NDC 0378-7280-85 D-0861-2017
Class III · Low risk

Tarina Fe 1/20

Chemical Contamination: out of specification results for impurities were found to be the result of contamination of product from vapors associated with paint thinner used in repair of the manufacturing room.

Terminated Chemical / undeclared Mylan Pharmaceuticals Inc. NDC 50102-128-01 D-0860-2017
Class III · Low risk

Buffered Lidocaine

Labeling; Label Mixup; outer packaging is incorrectly labeled as Buffered Lidocaine 1% instead of correctly as Buffered Lidocaine 0.9%

Terminated Labeling / mix-up Pharmedium Services, LLC D-0603-2017
Class III · Low risk

Dexamethasone Elixir

Failed Impurities/ Degradation Specifications

Terminated Impurity / degradation Vintage Pharmaceuticals LLC dba Qualitest Pharmaceuticals NDC 0603-1147-56 D-0438-2017
Class III · Low risk

Montelukast sodium tablets

Discoloration: the firm received a complaint of a sealed bottle in which tablets inside had blue spots and a blue powder inside the bottle.

Terminated Failed specification Hetero USA Inc NDC 31722-726-30 D-0623-2017
Class III · Low risk

Donepezil HCl tablets

Supotent: Out of Specification result for assay test during routine stability testing.

Terminated Wrong potency / content Mckesson Packaging Services NDC 63739-678-10 D-0680-2017

Recalls by year